Non-ischemic left ventricular dysfunction after pediatric cardiac transplantation: treatment with plasmapheresis and OKT3.

[1]  M. Mehra,et al.  Allosensitization in heart transplantation: implications and management strategies , 2003, Current opinion in cardiology.

[2]  H. Nakae,et al.  Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. , 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[3]  K. Groshart,et al.  Treatment of humoral rejection with rituximab. , 2002, The Annals of thoracic surgery.

[4]  J. Aranda,et al.  Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. , 2002, Transplantation.

[5]  J. Reeves.  A Review of Plasma Exchange in Sepsis , 2002, Blood Purification.

[6]  J. Tomaszewski,et al.  Successful reversal of severe refractory cardiac allograft rejection by photopheresis. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  Francis L. Delmonico,et al.  ACUTE HUMORAL REJECTION IN RENAL ALLOGRAFT RECIPIENTS: I. INCIDENCE, SEROLOGY AND CLINICAL CHARACTERISTICS1 , 2001, Transplantation.

[8]  C. Canter,et al.  Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: a multi-institutional study. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  R. Hetzer,et al.  Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  R. Montgomery,et al.  PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS , 2000, Transplantation.

[11]  C. Mavroudis,et al.  Reversal of severe late left ventricular failure after pediatric heart transplantation and possible role of plasmapheresis. , 2000, The American journal of cardiology.

[12]  Scott A. Chapman,et al.  Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  D. Mcnamara,et al.  Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  L. Wiklund,et al.  Plasmapheresis as a rescue therapy to resolve cardiac rejection with vasculitis and severe heart failure. A report of five cases , 1995, Transplant international : official journal of the European Society for Organ Transplantation.

[15]  D. McGiffin,et al.  Total lymphoid irradiation: is there a role in pediatric heart transplantation? , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  D. Renlund,et al.  Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  D. Pennington,et al.  Vascular rejection in heart transplant recipients. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  J. Myles,et al.  Successful treatment of acute humoral rejection in a heart transplant patient. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[20]  D. Renlund,et al.  Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. , 1989, The Journal of heart transplantation.

[21]  E Rene Rodriguez,et al.  The pathology of heart transplant biopsy specimens: revisiting the 1990 ISHLT working formulation. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  M. Fishbein,et al.  Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  R. Heitmiller.  Myasthenia gravis: clinical features, pathogenesis, evaluation, and medical management. , 1999, Seminars in thoracic and cardiovascular surgery.

[24]  J. Stark.  How to choose a cardiac surgeon , 1996 .

[25]  M. Masek,et al.  Reliability and usefulness of immunofluorescence in heart transplantation. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  S. Slavin,et al.  Total lymphoid irradiation. , 1987, Immunology today.